Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001638599-16-000828
Filing Date
2016-05-05
Accepted
2016-05-05 17:07:00
Documents
1
Period of Report
2016-05-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3_3921.html 3  
1 PRIMARY DOCUMENT doc3_3921.xml 3 10608
  Complete submission text file 0001638599-16-000828.txt   13612
Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161624860

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161624857

Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS. ADVISORS LP (Reporting) CIK: 0001263508 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161624858

Mailing Address 667 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 (212)339-5600
Baker Bros. Advisors (GP) LLC (Reporting) CIK: 0001580575 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161624859

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances